Logo image
Downregulation of signaling-active IGF-1 by dipeptidyl peptidase IV (DPP-IV)
Journal article   Peer reviewed

Downregulation of signaling-active IGF-1 by dipeptidyl peptidase IV (DPP-IV)

Ching-Ting Lin, Hsiang-Yun Tang, Yu-San Han, Hui-Ping Liu, Shiu-Feng Huang, Chia-Hui Chien, John Shyy, Jeng-Jian Chiu and Xin Chen
International Journal of Biomedical Science, Vol.6(4), pp.301-309
12/2010

Abstract

Dipeptidyl peptidase IV IGF binding protein 3 IGF signaling pathway Insulin-like growth factor-1 Biochemistry Genetics and Molecular Biology (all)
Functioning as an extracellular protease, dipeptidyl peptidase IV (DPP-IV) preferentially cleaves the peptide bond after the penultimate proline residue. We report here that DPP-IV cleaves the first two amino acids from insulin-like growth factor 1 (IGF-1), revealed by mass spectrometry. The kinetic parameters of the proteolytic cleavage indicate that this reaction is physiologically relevant. Interestingly, truncated IGF-1 is less potent than the full-length protein in activating the IGF-1R, but binds more readily to IGF-binding protein 3 (IGFBP3). Quantitative RT-PCR showed that the level of DPP-IV mRNA is dramatically lower in lung squamous cell carcinoma tissues than in adjacent nonneoplastic lung tissues. However, this reduction was not observed in lung adenocarcinoma tissues. Our study suggests a possible link between IGF-1 and DPP-IV in cancer development in a specific tumor niche. A DPP-IV-related pathway may be important in mitigating IGF-1 signaling. Consequently, a robust IGF signaling pathway may accelerate early carcinogenesis in environments lacking DPP-IV.

Metrics

1 Record Views

Details

Logo image